abstract |
The invention relates to thienopyrimidines of the formula (I) and their physiologically compatible salts, where R<1>, R<2> and X have the meanings given in claim 1. These thienopyrimidines have a phosphodiesterase-V inhibiting action and can be used for the treatment of cardiovascular diseases and for the preventive and/or curative treatment of impotence. |